In This Section
Xiao-Feng Yang, MD, PhD, FAHA
Director, Graduate Education and Professor, Cardiovascular Research Center
Professor, Cardiovascular Sciences
Professor, Center for Metabolic Disease Research
Professor, Microbiology, Immunology & Inflammation
Professor, Sol Sherry Thrombosis Research Center
Professor, Biomedical Education & Data Science
Co-Director, Center for Inflammation, Translational and Clinical Lung Research
- Contact Information
- About Me
- Vascular immunology and atherosclerosis. Dr. Yang’s laboratory uses microarray transcriptome, next generation DNA sequencing including RNA-Seq, T cell epitope mapping, SEREX and other biochemical, immunological approaches and transgene/gene knock-out disease models in order to determine cardiovascular disease (CVD) risk factors, such as hyperlipidemia-, hyperglycemia-, uremia-, endotoxemia, impact the development/progression of vascular inflammation and atherosclerosis.
- Immunometabolism. Dr. Yang’s laboratory also aims to study how biochemical metabolites in CVD-related pathologies act as either danger signals or homeostatic signals to regulate antigen processing/presentation, vascular immune responses and atherosclerosis.
- Epigenetic pathology. Dr. Yang’s laboratory also studies how CVD risk factors regulate histone modification process and gene expressions in vascular inflammation and atherosclerosis.
- Education, Training & Credentials
- Fellowship, Immunology and Oncology, Harvard Medical School, 1999
- PhD, Biochemistry and Molecular Biology, University of Montreal, Canada 1994
- MS, Immunology, Chinese National Academy of Medical Sciences and Peking Union Medical University 1982
- MD, Clinical Medicine, JiangXi Medical University, China 1979